首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: Effect of age in the Medicine, Angioplasty, or Surgery Study II trial
【24h】

Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: Effect of age in the Medicine, Angioplasty, or Surgery Study II trial

机译:随机接受手术,血管成形术或药物治疗的稳定多支冠状动脉疾病患者的十年结局:医学,血管成形术或手术研究II试验中年龄的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: With progressive aging, coronary artery disease has been diagnosed at more advanced ages. Although patients aged 65 years or more have been referred to surgical or percutaneous coronary interventions, the best option for coronary artery disease treatment remains uncertain. The current study compared the 3 treatment options for coronary artery disease in patients aged 65 years or more and analyzed the impact of age in treatment options. Methods: Patients were separated according to age: 65 years or more (n = 200) and less than 65 years (n = 411). All patients were followed for 10 years. The rates of overall mortality, acute myocardial infarction, and new revascularizations were analyzed. Results: Of 200 patients aged 65 years or more, 68 were randomized to medical therapy, 68 were randomized to percutaneous coronary intervention, and 64 were randomized to coronary artery bypass grafting. At 10 years, overall survival was 63% (medical therapy), 69% (percutaneous coronary intervention), and 66% (coronary artery bypass grafting) (P =.93). The survival free of combined events was 43% (medical therapy), 38% (percutaneous coronary intervention), and 66% (coronary artery bypass grafting) (P =.007). The survival free of myocardial infarction was 82% (medical therapy), 77% (percutaneous coronary intervention), and 90% (coronary artery bypass grafting) (P =.17), and survival free of new revascularizations was 59% (medical therapy), 58% (percutaneous coronary intervention), and 91% (coronary artery bypass grafting) (P =.0003). When the 2 age groups were compared, survival free of myocardial infarction for patients treated by percutaneous coronary intervention was 77% (older patients) and 92% (younger patients) (P =.004). Conclusions: In this analysis, treatment options for patients aged 65 years or more who have coronary artery disease yield similar overall survival. However, coronary artery bypass grafting was associated with fewer coronary events, and percutaneous coronary intervention was associated with a higher incidence of myocardial infarction.
机译:目的:随着年龄的增长,已经诊断出冠状动脉疾病的年龄更高。尽管已经对65岁或65岁以上的患者进行了外科或经皮冠状动脉介入治疗,但仍不确定冠状动脉疾病治疗的最佳选择。当前的研究比较了65岁或65岁以上患者的三种冠心病治疗方案,并分析了年龄对治疗方案的影响。方法:根据年龄划分患者:65岁或以上(n = 200)且小于65岁(n = 411)。所有患者均随访10年。分析了总死亡率,急性心肌梗塞和新的血运重建率。结果:在200名65岁或65岁以上的患者中,有68例被随机分配到药物治疗,68例被随机分配到经皮冠状动脉介入治疗,64例被随机分配到冠状动脉搭桥术。在10年时,总生存率为63%(药物治疗),69%(经皮冠状动脉介入治疗)和66%(冠状动脉搭桥术)(P = .93)。没有合并事件的存活率为43%(药物治疗),38%(经皮冠状动脉介入治疗)和66%(冠状动脉搭桥术)(P = .007)。无心肌梗死的存活率为82%(药物治疗),77%(经皮冠状动脉介入治疗)和90%(冠状动脉搭桥术)(P = .17),无新血运重建的存活率为59%(药物治疗) ),58%(经皮冠状动脉介入治疗)和91%(冠状动脉搭桥术)(P = .0003)。当比较这两个年龄组时,经皮冠状动脉介入治疗的患者无心肌梗死的存活率为77%(老年患者)和92%(年轻患者)(P = .004)。结论:在此分析中,年龄在65岁或以上的患有冠状动脉疾病的患者的治疗选择具有相似的总体生存率。但是,冠状动脉搭桥术与较少的冠状动脉事件相关,而经皮冠状动脉介入治疗与较高的心肌梗死发生率相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号